There is a preponderance of receptors of incretin-based therapies (for example, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1)-based receptor agonists) in central nervous system nuclei, including the hypothalamus and NAc, which regulate energy balance and reward processing 6,7 , underlying their therapeutic potential for obesity and type 2 diabetes 8,9,10
Role of oxidative stress in development of cardiovascular complications in diabetes mellitus
One study suggested that a 2 oz snack of pistachios increased release of the hormone while improving other hormonal and blood sugar factors as well
You agree to defend, indemnify, and hold harmless the Company from any claims or expenses arising from misuse, unauthorized use, or violation of any law or third-party rights
Our Best GLP-1 Telehealth Programs of 2026 guide covers the national programs that ship to Florida
The automatic dose escalation feature reduces the need for frequent provider interactions around dose changes, which some patients view as a convenience and others may see as reduced clinical touchpoints